Vizionfocus, Inc. (4771) AI Stock Analysis

Vizionfocus, Inc.

(TWSE:4771)

Select Model

Rating:74Outperform

Price Target:TWD 224.00▲(24.44% Upside)

Action:initiatedcoverage

Date:11/10/26

Strong financial performance driven by revenue growth and balance sheet improvement is the main positive factor, supported by attractive valuation; short-term technical momentum shows mild weakness.

Positive Factors

Revenue and EPS GrowthStrong revenue and EPS growth indicate expanding business scale and improving earnings power. If sustained, this combination can support reinvestment, strengthen the company’s competitive position, and provide a durable foundation for profit growth over the next several quarters.

Negative Factors

Volatile Free Cash FlowRepeated negative free cash flow makes cash conversion less predictable even though operating cash flow remains positive. Heavy reinvestment or working-capital needs can reduce financial flexibility, constrain internally funded expansion, and make reported earnings less readily available for discretionary uses.

Vizionfocus, Inc. (4771) vs. SPDR S&P 500 ETF (SPY)

Market Cap: TWD 10.51B
Dividend Yield: 3.87%
Average Volume (3M): 222.84K
Price to Earnings (P/E): 11.1
Beta (1Y): 0.51
Revenue Growth: 31.09%
EPS Growth: 33.78%
Country: TW
Employees: 486
Sector: General
Sector Strength: 55
Industry: Medical - Instruments & Supplies

Vizionfocus, Inc. Business Overview & Revenue Model

Company Description

Established in 2011 and based in Miaoli, Taiwan, Vizionfocus Inc. operates as a manufacturer of various sophisticated products. The company primarily produces medical equipment, serving key markets across Taiwan, China, Japan, and the United States....

Vizionfocus, Inc. Financial Statement Overview

Summary

Strong revenue growth, improving margins, and solid profitability from the income statement, combined with reduced leverage on the balance sheet, though offset by free cash flow volatility.

Income Statement

87Very Positive

Balance Sheet

81Very Positive

Cash Flow

68Positive

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	4.03B	3.49B	3.00B	2.57B	1.83B	1.42B
Gross Profit	1.66B	1.43B	1.18B	1.03B	697.43M	491.81M
EBITDA	1.55B	1.42B	1.30B	1.13B	748.91M	500.02M
Net Income	915.25M	740.77M	669.59M	562.28M	312.99M	234.13M
Balance Sheet
Total Assets	8.16B	7.06B	5.94B	4.46B	3.21B	2.89B
Cash, Cash Equivalents and Short-Term Investments	1.09B	1.29B	1.43B	800.16M	918.50M	580.88M
Total Debt	1.81B	1.59B	1.34B	1.73B	763.60M	785.18M
Total Liabilities	3.53B	2.64B	2.09B	2.43B	1.19B	1.08B
Stockholders Equity	4.14B	3.98B	3.53B	1.79B	1.64B	1.42B
Cash Flow
Free Cash Flow	-635.71M	-78.24M	197.41M	-435.20M	465.69M	-51.61M
Operating Cash Flow	1.18B	1.07B	1.14B	958.65M	757.76M	388.97M
Investing Cash Flow	-1.62B	-1.23B	-1.21B	-1.39B	-288.21M	-392.68M
Financing Cash Flow	121.03M	-47.06M	426.19M	325.25M	-133.98M	280.26M

Vizionfocus, Inc. Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

TW:4771 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TW:4771	74Outperform	TWD 10.63B	11.11	―	3.87%	31.09%	33.78%
TW:3218	73Outperform	TWD 10.68B	9.40	―	6.15%	0.24%	28.93%
TW:6667	64Neutral	TWD 12.62B	12.58	―	4.56%	28.55%	55.47%
TW:4908	59Neutral	TWD 13.26B	72.71	―	0.57%	4.39%	9.57%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
TW:6209	52Neutral	TWD 13.55B	33.30	―	0.63%	66.86%	―

* General Sector Average

Performance Comparison

TW:4771 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
TW:4771	Vizionfocus, Inc.	180.00	7.42	4.30%
TW:3218	Universal Vision Biotechnology Co., Ltd.	126.00	-22.69	-15.26%
TW:4908	APAC Opto Electronics Inc.	175.50	102.88	141.67%
TW:6209	Kinko Optical Co. Ltd.	78.50	25.38	47.78%
TW:6667	Trusval Technology Co., Ltd.	249.00	27.69	12.51%
TW:7932	e-Ray Technology Co., Ltd.	201.50	-193.50	-48.99%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 09, 2026

Vizionfocus, Inc. AI Stock Analysis